Report overview
Leptospirosis, staphylococcal infection, bacterial ear infection, actinomycosis, and nocardiosis are some of the most common forms of infections in pets. Moreover, pets are susceptible to bacterial diseases, such as plague, brucellosis, and Lyme disease. Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an organism infectious or by killing the infectious organism outright.This term encompasses antibiotics, antifungals etc.
This report aims to provide a comprehensive presentation of the global market for Pets Anti-infective Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pets Anti-infective Drugs. This report contains market size and forecasts of Pets Anti-infective Drugs in global, including the following market information:
Global Pets Anti-infective Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pets Anti-infective Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Pets Anti-infective Drugs companies in 2022 (%)
The global Pets Anti-infective Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In the China market, core pets anti-infective drugs manufacturers include Zoetis, Merck and Elanco etc. The Top 3 companies hold a share above 40%.
We surveyed the Pets Anti-infective Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pets Anti-infective Drugs Market, by Administration Method, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pets Anti-infective Drugs Market Segment Percentages, by Administration Method, 2022 (%)
External Use
Internal Use
Injection
Global Pets Anti-infective Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pets Anti-infective Drugs Market Segment Percentages, by Application, 2022 (%)
Dog
Cat
Others
Global Pets Anti-infective Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pets Anti-infective Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pets Anti-infective Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pets Anti-infective Drugs revenues share in global market, 2022 (%)
Key companies Pets Anti-infective Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Pets Anti-infective Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zoetis
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva Sant? Animale
Vetoquinol
Nanjing Jindun Animal
Wuhan Chopperlvya
Bimeda Animal Health
Ouro Fino Saude
Norbrook
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pets Anti-infective Drugs, market overview.
Chapter 2: Global Pets Anti-infective Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Pets Anti-infective Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by administration method, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pets Anti-infective Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pets Anti-infective Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
